25 May 2013
Keywords: India, Biologic regulations, Biosimilars
Article | 26 January 2012
Currently, all biologics in India, including innovative and copy biologics are approved as new drugs, notes a new report added ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
26 January 2012
25 January 2012
24 May 2013
© 2013 thepharmaletter.com